HPTN Publications

Hall M, Golubchik T, Bonsall D, Abeler-Dörner L, Limbada M, Kosloff B, Schaap A, de Cesare M, MacIntyre-Cockett G, Otecko N, Probert W, Ratmann O, Bulas Cruz A, Piwowar-Manning E, Burns DN, Cohen MS, Donnell DJ, Eshleman SH, Simwinga M, Fidler S, Hayes R, . Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study. Lancet Microbe. 2024, 5: e62-e71

Hall, G. C., Young, A., Krakauer, C., Watson, C. C., Cummings, V., Mayer, K., Koblin, B. . Sexual Risk Behaviors Among Black Men Who Have Sex With Men Who Also Report Having Sex With Transgender Partners: Analysis of HIV Prevention Trials Network (HPTN) 061 Study.. AIDS Educ Prev. 2017, 29: 418-431

hamilton el, Guo X, Dadabhai S, Panchia R, Ogendo A, Reynolds D, Chen Y, Sandfort TGM; HPTN 075 study team. . Stigma and other correlates of self-esteem and depression in cisgender men and transfeminine persons with HIV who have sex with men in Kenya, Malawi, and South Africa (HPTN 075). AIDS Care. 2025, 37: 1181-1193

Han K, Patel P, McCallister S, Rinehart AR, Gandhi Y, Spreen W, Landovitz RJ, Delany-Moretlwe S, Marzinke MA, McKeon T, Budnik P, van Wyk J, Ford SL . Long-acting cabotegravir pharmacokinetics with and without oral lead-in for HIV PrEP. Antimicrob Agents Chemother.

Hanass-Hancock J, Carpenter B, Reddy T, Nzuza A, Gaffoor Z, Goga A, Andrasik M . Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa. Trials. 2022, 22: 897

Hanrahan D, Sexton P, Hui K, Teitcher J, Sugarman J, London AJ, Barnes M, Purpura J, Klitzman R . Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies. PLoS One. 2015, 10: e01333394

Hanscom B, Marzinke MA, Li X, Donnell D, Bies R, Hendrix CW, Wang Z, Acuipil C, Rinehart A, Collins JW, Rooney JF, Soto Torres L, Richardson P, Chariyalerstsak S, Valdez Ramalho Madruga J, Hurt CB, Magnus M, Frank I, McCauley M, Grinsztejn B, Landovitz RJ . Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083. J Infect Dis.

Hanscom BS, Donnell DJ, Fleming TR, Hughes JP, McCauley M, Grinsztejn B, Landovitz RJ, Emerson SS . Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial.. Clin Trials.